Propel Bio Management, LLC has disclosed 22 total holdings in their latest 13F filing with the SEC for the portfolio
date of 2024-06-30. The current portfolio value is calculated to be $154.00 Mil. The turnover rate is 26%.
In Propel Bio Management, LLC's current portfolio as of 2024-06-30, the top 5 holdings are
Applied Therapeutics Inc (APLT), Plains GP Holdings LP (PAGP), TScan Therapeutics Inc (TCRX), Madrigal Pharmaceuticals Inc (MDGL), Achieve Life Sciences Inc (ACHV), not including call and put options.
Propel Bio Management, LLC did not buy any new stocks in the current portfolio.
Please visit the "Current Portfolio" tab to see the current and past 13F holdings for Propel Bio Management, LLC, as well as holding map,
valuations for each stock, which positions are undervalued, have low PE Ratios, are considered high quality and recently traded at
52-week lows, etc.
Please visit the "Stock Picks" tab to see the latest guru trades and stock picks for Propel Bio Management, LLC, which include data from
13F quarterly reports, 13D/G beneficial ownership reports and form 4 insider ownership change reports.
Please visit the "Summary" page to see the top 10 holdings, recent stock picks, performance, sector / industry breakdown details, as well as past holding history summary for Propel Bio Management, LLC.